Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • T vs MRNA✓SelectedUSD · MRNAT vs MRNA performance historyLatest closeAs of+2.11%11/20
Stock and ETF performance explorer

T vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+70.1%
MRNA return
+786.4%
Excess return
-716.2%
Maximum drawdown
-39.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+2.1%-2.2%+4.3%+2.1%
7D+0.6%-12.7%+13.3%+0.7%
30D+1.8%-20.7%+22.5%+1.9%
3M-10.3%+46.3%-56.6%-10.6%
6M-8.3%+305.2%-313.5%-10.2%
YTD-5.9%+561.2%-567.1%-8.9%
1Y-8.4%+772.1%-780.5%-11.9%
3Y+61.1%+147.0%-85.9%+58.0%
5Y+63.2%-26.1%+89.2%+62.2%
All+70.1%+786.4%-716.2%+51.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling